Breaking News
November 20, 2018 - Towards finding a druggable cancer target
November 20, 2018 - Ultragenyx Announces Intent to Submit New Drug Application to U.S. FDA for UX007 for the Treatment of Long-chain Fatty Acid Oxidation Disorders in Mid-2019
November 20, 2018 - Cooling ‘brains on fire’ to treat Parkinson’s
November 20, 2018 - Less pollution could increase the average lifespan of Copenhageners by an entire year in 2040
November 20, 2018 - Abramson Cancer Center becomes the 28th member institution of National Comprehensive Cancer Network
November 20, 2018 - The plug and play time-resolved spectrometer from PicoQuant
November 20, 2018 - Breakthrough technology offers new hope to people with glaucoma, retinitis and macular degeneration
November 20, 2018 - New report highlights key focus areas to help cancer screening realize its full potential
November 20, 2018 - International experts to discuss strategies to maintain spatial orientation in old age
November 20, 2018 - Scientists discover new inhibitor that decreases lung inflammation
November 20, 2018 - Participation project calls for relaxing research ban on germline interventions
November 20, 2018 - Karyopharm’s Selinexor Receives Fast Track Designation from FDA for the Treatment of Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma
November 20, 2018 - Arthritis by the Numbers: Book of Trusted Facts & Figures
November 20, 2018 - Drug homing method helps rethink Parkinson’s
November 20, 2018 - AHF commends the passage of global AIDS funding in the House, calls for swift approval
November 20, 2018 - The search for new psychiatric disorder treatments
November 20, 2018 - New research offers hope for simpler way to diagnose and treat cancer
November 20, 2018 - Study sheds light on the infection mechanism of influenza virus
November 20, 2018 - Storage failures of eggs and embryos gain a new perspective
November 20, 2018 - Buyers of short-term health plans: Wise or shortsighted?
November 20, 2018 - Study indicates that frogs in virus-exposed groups breed at young age
November 20, 2018 - FDA Alerts Health Care Professionals and Patients Not To Use Sterile Drug Products from Pharm D Solutions
November 20, 2018 - Asthma may contribute to childhood obesity epidemic
November 20, 2018 - Researchers to explore the enigmatic role of unstructured protein in regulating circadian function
November 20, 2018 - Many patients with adenomas do not receive colonoscopy within recommended time frame
November 20, 2018 - Drug used to treat PTSD does not reduce suicidal thinking, may worsen nightmares and insomnia
November 20, 2018 - In-person social contact may offer protection against depression and PTSD symptoms
November 20, 2018 - Routine HCV testing in correctional facilities can best identify and treat disease, say researchers
November 20, 2018 - Molecular DNA analysis could facilitate more accurate prognosis, treatment of aggressive brain tumors
November 20, 2018 - Breast Cancer Recurrence Rate Not Up With Autologous Fat Transfer
November 20, 2018 - Beta 2 Microglobulin (B2M) Tumor Marker Test: MedlinePlus Lab Test Information
November 20, 2018 - Could bariatric surgery make men more virile?
November 20, 2018 - Urine test to check if patients take their medications will save the NHS money, say researchers
November 20, 2018 - Study reveals impact of residual inflammatory risk on clinical outcomes after PCI
November 20, 2018 - RNAi therapy shown to alleviate preeclampsia
November 20, 2018 - Replacement of dysfunctional microglia has therapeutic potential for neurodegenerative diseases
November 20, 2018 - Forming 3D Neuronal Models of the Brain
November 20, 2018 - Shoulder ultrasounds could be used to predict diabetes
November 20, 2018 - SGLT2 Inhibitors for Diabetes Linked to Increased Risk for Amputation
November 20, 2018 - Stem cell transplant cements Arizona men’s father-son bond
November 20, 2018 - Scientists try to develop portable systems that can quickly produce biologics on demand
November 20, 2018 - Automating Data Capture and Image Analysis in Continuous Experiments
November 20, 2018 - New drug shows promise for treating people with peanut allergy
November 20, 2018 - Researchers develop novel mouse model to study immunomodulatory therapies
November 20, 2018 - “Britain must not go backward on antibiotic controls to appease US trade deals” – Jim Moseley, CEO of Red Tractor
November 20, 2018 - Widespread errors in ‘proofreading’ cause inherited blindness
November 20, 2018 - Reaping the benefits of living longer
November 20, 2018 - New Program Hopes to Make Early Detection and Treatment of ALS a Reality
November 19, 2018 - Artificial bone-like substance mimics the way real bone grows at atomic level
November 19, 2018 - FDA Grants Orphan Drug Designation To RGX-181 Gene Therapy For The Treatment Of CLN2 Form Of Batten Disease
November 19, 2018 - Systemic mastocytosis – Genetics Home Reference
November 19, 2018 - Eye trauma secondary to falls in older adults increasing
November 19, 2018 - Empowering women in India to improve their health: A Q&A
November 19, 2018 - Researchers have trained a computer to analyze breast cancer images and classify tumors
November 19, 2018 - New glucose binding molecule could be key to better metabolic control for diabetics
November 19, 2018 - Biologists uncover novel genetic control of lipid maintenance and its potential connection to lifespan
November 19, 2018 - Warmer winters may set scene for higher rates of violent crimes
November 19, 2018 - Personalized program of physical exercise effective in reversing functional decline in the elderly
November 19, 2018 - Acacia Pharma Resubmits Barhemsys New Drug Application
November 19, 2018 - PDL1 (Immunotherapy) Tests: MedlinePlus Lab Test Information
November 19, 2018 - Transforming pregnancy research with a smartphone app
November 19, 2018 - Stanford Medicine magazine explores how digital technology is changing health care
November 19, 2018 - Vision impairments may increase risk of falls in older adults
November 19, 2018 - Concomitant use of sleeping pills and opioids found to prevalent among people with Alzheimer’s disease
November 19, 2018 - Marijuana prevention programs should focus on promoting mental wellbeing of youth
November 19, 2018 - New report calls for greater awareness and emphasis on scale and impact of atrial fibrillation
November 19, 2018 - In throes of turkey salmonella outbreak, don’t invite illness to your table
November 19, 2018 - UK health policies should be redesigned to become more accessible for men
November 19, 2018 - Short Interpregnancy Intervals Tied to Adverse Outcome Risk
November 19, 2018 - New mothers’ breastfeeding pain can affect infant health
November 19, 2018 - Stanford Medicine magazine reports on ways digital technology is transforming health care | News Center
November 19, 2018 - Human drugs alter cricket personality
November 19, 2018 - Insilico Medicine to introduce ‘Cure a disease in a year’ program at Biodata World Congress 2018
November 19, 2018 - Experts debate over whether gut or brain is more important in regulating appetite
November 19, 2018 - Playing on fear and fun, hospitals follow pharma in direct-to-consumer advertising
November 19, 2018 - 2PG Company receives grant to develop sensitive, low-cost molecular diagnostic tests for tuberculosis
November 19, 2018 - Low-Carb Diets May Work By Boosting Calorie Burn
November 19, 2018 - Key molecule responsible for learning and memory discovered
November 19, 2018 - New blood test developed for early diagnosis of ovarian cancer
November 19, 2018 - Researchers identify molecule to fight myotubular myopathy
Sleep disorders appear to be first sign of serious neurological diseases

Sleep disorders appear to be first sign of serious neurological diseases

image_pdfDownload PDFimage_print

Sleep disorders are often the first sign of serious neurological diseases. Neurologists should inquire extensively about the quality of their patients’ sleep. This point was emphasized by experts at the Congress of the European Academy of Neurology in Lisbon. In rare neuroimmunological diseases sleep and wakefulness also frequently play an important role.

If patients report suffering from sleep disorders, alarm bells should go off for neurologists. These conditions are often a first sign of serious neurological diseases. This is true of abnormal sleep behavior as well as excessive sleepiness or insomnia. “Two thirds of the population suffering from REM sleep disorders later develop Parkinson’s disease, Lewy body dementia or multiple system atrophy,” Dr Konstanze Philipp (Munster) reported at the 4th Congress of the European Academy of Neurology (EAN) in Lisbon.

REM sleep behavior disorder (Schenk syndrome) manifests itself in the loss of what is known as physiological muscle atonia during REM sleep. This paralysis causes muscles to relax in healthy sleeping individuals who are dreaming. If this inhibition is lost, the affected individuals move, cry out, and flail around with their arms and legs during the REM sleep and can injure themselves and their partner. In combination with certain biological markers, these neurodegenerative diseases could be diagnosed in the future years before the first consciously perceived symptoms occur. However, anyone looking through health records for a patient’s documented sleep history seldom finds one. Dr Philipp: “We have to raise awareness on this matter. Improved early detection in the future could also improve the therapeutic results.” For instance, there is the well-founded hope that new therapeutic approaches can prevent, or at least delay, the breakout of Parkinson’s disease, provided treatment begins very early on.

Active while sleeping – possible sign of autoimmune disease

Insomnia or poor sleep quality can also indicate rare neuroimmunological illnesses caused by antibodies. Dr Philipp illustrated this point at the EAN Congress by citing three cases as examples. Case 1: A 69-year-old man reported he had recently been very active in his sleep, causing him to fall out of bed twice. He went on to say that his sleep was no longer restful and that he kept falling asleep involuntarily during the day. A few months later, the man developed gait abnormalities, had ocular motor problems, and also chorea-like movement disorders entailing involuntary, jerky and irregular movements. It was not until then that he was diagnosed with an autoimmune disorder discovered just a few years ago, namely, anti-IgLON5 disease or autoimmune encephalopathy with parasomnia and obstructive sleep apnoea. The syndrome is characterized by a complex, advanced sleep disorder and is triggered by antibodies against IgLON5, a neural cell adhesion molecule.

Sleepiness during the day or insomnia as initial signals

The two other examples that Dr Philipp cited from her case analyses are as follows. Case 2: After a long investigation, a 33-year-old man was diagnosed with Ma2 antibody encephalitis caused by a germ cell tumor. A year and a half prior to the diagnosis, the young man had already been suffering from extreme daytime sleepiness, hypnagogic hallucinations, and sleep paralysis. It was not until a sleep lab determined he had narcolepsy originating in the central nervous system that his physicians began zeroing in on the actual problem and the right diagnosis. Case 3: For a 51-year-old patient, sleep disorders were also the first signals of a severe neuroimmunological disease. He suffered from insomnia for two years. Then various muscular symptoms such as myalgia, cramps and fasciculations occurred. At that point his physicians finally diagnosed him as having Morvan’s syndrome, a type of autoimmune encephalitis associated with antibodies against the Contactin-associated protein 2 (CASPR2).

Dr Philipp made this appeal: “Asking questions, listening and documenting are least expensive and easiest ways of diagnosing these complex diseases. We should use them. The therapeutic approaches are still expandable. Nonetheless, early detection is essential, especially for neurodegenerative disorders.”

Tagged with:

About author

Related Articles